Amgen, TKTX aftermath

AMGN was up $7.625 (13 percent) to $67.625 on Monday, and Transkaryotic Therapies (TKTX) was off $10.875 (32 percent) to $23.125, with a market cap of $524.8 million following last Friday's after-market ruling by Judge

Read the full 352 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE